Alcon Inc. Ordinary Shares (ALC)
Stock · NYSE · Health Care
$72.03as of 8/28/2026
Price chart
Open in TradingViewActive signals
About ALC
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical proced…
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Employees
- 25,000
- Website
- www.alcon.ch/
Fundamentals
- 1-day range
- $71.38$72.07
- Market cap
- $34.75B
- P/E (trailing)
- 44.50
- P/E (forward)
- 18.10
- EPS (trailing)
- $1.66
- Dividend yield
- 0.32%
- Beta
- 1.13
- Avg. volume
- 1.97M
- Ex-dividend date
- May 6, 2026
- Dividend pay date
- May 7, 2026
Forecasts
15 analyst ratings
Alcon Inc. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- ALCAlcon Inc. Ordinary Shares$72.03▼ 0.28%Market cap $34.75BP/E 44.50$47.8$68.34
- COOThe Cooper Companies Inc. Common Stock$71.15▲ 0.27%Market cap $14.30BP/E 63.74$58.89$89.83
- BLCOBausch + Lomb Corporation Common Shares$17.15▲ 0.12%Market cap $5.84BP/E —$13.77$18.92
- WRBYWarby Parker Inc. Class A Common Stock$25▼ 1.07%Market cap $3.31BP/E 401.34$14.96$31
- EYENational Vision Holdings Inc. Common Stock$17.37▼ 2.80%Market cap $1.80BP/E 34.05$14.75$30.02
- STAASTAAR Surgical Company Common Stock$22.1▼ 1.30%Market cap $1.15BP/E 327.25$15.59$35.87
- LUCYInnovative Eyewear Inc. Common Stock$0.97▲ 3.08%Market cap $6.19MP/E —$0.65$2.24
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ALC Alcon Inc. Ordinary Shares | $34.75B | 44.50 | $72.03 | ▼ 0.28% | $47.8$68.34 |
| COO The Cooper Companies Inc. Common Stock | $14.30B | 63.74 | $71.15 | ▲ 0.27% | $58.89$89.83 |
| BLCO Bausch + Lomb Corporation Common Shares | $5.84B | — | $17.15 | ▲ 0.12% | $13.77$18.92 |
| WRBY Warby Parker Inc. Class A Common Stock | $3.31B | 401.34 | $25 | ▼ 1.07% | $14.96$31 |
| EYE National Vision Holdings Inc. Common Stock | $1.80B | 34.05 | $17.37 | ▼ 2.80% | $14.75$30.02 |
| STAA STAAR Surgical Company Common Stock | $1.15B | 327.25 | $22.1 | ▼ 1.30% | $15.59$35.87 |
| LUCY Innovative Eyewear Inc. Common Stock | $6.19M | — | $0.97 | ▲ 3.08% | $0.65$2.24 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- SGA Exits Alcon (ALC) as Cataract Demand Slows and Competition RisesYahoo · 8/24/2026
- GKOS Stock Surges 67% Year to Date: What's Driving the Rally?Yahoo · 8/20/2026
- What Makes Alcon (ALC) a Bullish Bet?Yahoo · 8/19/2026
- COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?Yahoo · 8/18/2026
- Bill Ackman Bets Big on Visa After It Lagged the Market for 5 Years. Should You?Yahoo · 8/18/2026
- Alcon (ALC) Q2 2026 Earnings Call TranscriptYahoo · 8/17/2026
- Why Is Netflix Stock Falling on Monday?Benzinga · 8/17/2026
- Bill Ackman lost $400M dumping Netflix — now says it ‘won the streaming wars.’ Should you rebuy a stock that burned you?Yahoo · 8/17/2026
- S&P 500 Surges To Record Close Following Jobs Data: Investor Sentiment Improves, Fear Index Remains in ‘Greed’ Zonebenzinga · 8/10/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 29, 2026
SGA exits Alcon stake, cites weaker cataract demand and rising competition. SGA, a long-time shareholder, has sold its position in Alcon, pointing to slower demand in the cataract business and increasing competition in the market. The exit comes as Alcon's shares trade well above their 52-week range of $47.80-$68.34, with an average analyst price target of $85.24 suggesting the stock is currently priced above most peer valuations. Technical indicators also show signs of pressure, with a one-year and six-month revenue-price divergence noted, alongside repeated tests of the $72.82 support level.